We are live on ! Find out more
BCYC

Bicycle Therapeutics
BCYC

14 hedge funds and large institutions have $81.9M invested in Bicycle Therapeutics in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more capital invested

Capital invested by funds: $55.7M → $81.9M (+$26.2M)

40% more funds holding

Funds holding: 10 → 14 (+4)

0.26% more ownership

Funds ownership: 20.08% → 20.33% (+0.26%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

Holders
14
Holders Change
+4
Holders Change %
+40%
% of All Funds
0.31%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
4
Increased
3
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
+$1.07M
2
Renaissance Technologies
Renaissance Technologies
New York
+$240K
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$229K
4
Squarepoint
Squarepoint
New York
+$167K
5
Morgan Stanley
Morgan Stanley
New York
+$41.3K

Top Sellers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
-$511K
2
LCM
Laurion Capital Management
New York
-$209K
3
Millennium Management
Millennium Management
New York
-$75.8K

BCYC Hedge Fund Activity: Q1 2020 in Review

14 of the 4,548 institutional investors tracked by Wall St. Rank reported a position in Bicycle Therapeutics (BCYC) for Q1 2020, worth a combined $81.9M — up 47% from $55.7M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new BCYC positions and 0 closed out — a net gain of 4 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Victory Capital Management, adding an estimated $1.07M. The largest seller was Pentwater Capital Management, cutting an estimated $511K.

  • 14 institutional investors held Bicycle Therapeutics (BCYC) as of Q1 2020, up from 10 in Q4 2019.
  • Funds reported $81.9M of Bicycle Therapeutics stock for Q1 2020, up 47% quarter-over-quarter.
  • 4 funds opened new Bicycle Therapeutics positions in Q1 2020 and 0 closed out, a net change of +4 holders.
  • The largest Bicycle Therapeutics buyer in Q1 2020 was Victory Capital Management, an estimated $1.07M added.
  • The largest Bicycle Therapeutics seller in Q1 2020 was Pentwater Capital Management, an estimated $511K sold.

Based on aggregated 13F filings for Q1 2020.